OnKure Therapeutics Inc. (OKUR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
2.71
-0.09 (-3.21%)
At close: Oct 03, 2025, 3:59 PM
2.76
1.85%
After-hours: Oct 03, 2025, 06:55 PM EDT

OnKure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-52.67M -35.31M -29.51M -39.77M
Depreciation & Amortization
662K 560K 387K 50K
Stock-Based Compensation
4.53M 199K 48K n/a
Other Working Capital
1.98M -1.71M 2.12M -2.8M
Other Non-Cash Items
316K n/a n/a 4.54M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3.95M 6K 2.12M -2.8M
Operating Cash Flow
-51.12M -34.55M -26.95M -37.98M
Capital Expenditures
-52K -246K -1.13M -198K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -31.41M
Sales Maturities Of Investments
15.93M n/a 44.1M 8.23M
Other Investing Acitivies
n/a n/a -44.1M n/a
Investing Cash Flow
15.87M -246K -1.13M -23.38M
Debt Repayment
6M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51.22M -723K -1.38M n/a
Financial Cash Flow
116.13M 53.13M 26.46M 132.41M
Net Cash Flow
80.89M 18.33M -1.62M 71.05M
Free Cash Flow
-51.17M -34.79M -28.09M -38.18M